272 / 337
272
OVERVIEW BY TOPICS
PROGRAMME OVERVIEW
BY TOPICS
TOPIC 1:
Neurocognitive disorders, organic
mental disorders, dementia, F0
HS-14
|
Main Symposium
287
Prevention of dementia
ST-16
|
State-of-the-Art-Symposium
287
Dementia
TOPIC 3:
Psychotic disorders, F2
B-08
|
Special Session
284
Breakthroughs in Psychiatry: Are there
innovations in the pharmacotherapy of
Schizophrenia foreseeable? State of the
art and new directions
S-075
|
Symposium
286
Cognitive behaviour therapy for psycho-
sis: Evidence based efficacy and novel
approaches
PL-02
|
Plenary Session
286
Pathogenic mechanisms in early psy-
chosis: implications for diagnosis and
treatment
ST-12
|
State-of-the-Art-Symposium
286
Psychotic Disorders
S-104
|
Symposium
288
The role of oligodendrocytes in symp-
tom dimensions of schizophrenia
S-168
|
Symposium
290
Schizophrenia (Imaging) Genetics: From
bench to bedside – The next steps
TOPIC 4:
Affective disorders, F3
PC-01
|
Pro-Con-Debate
283
Effects of selective serotonin re-uptake
inhibition on mortality, morbidity
and mood in depressed heart failure
patients
ST-15
|
State-of-the-Art-Symposium
287
Recent developments in the treatment
of unipolar depressions
TOPIC 5:
Neurotic, stress-related and somato-
form disorders, F4
B-22
|
Special Session
282
Trauma and migration – Refugees and
asylum seekers in mental health care
L-05
|
Lecture
287
Let‘s not make a bad thing worse
PL-04
|
Plenary Session
291
Neurobiological and psychiatric conse-
quences of child maltreatment
TOPIC 8:
Disorders closely related to childhood
and adolescence, F7-9
PL-03
|
Plenary Session
289
Parent-infant synchrony and the cross-
generation transmission of psychopa-
thology and resilience
TOPIC 9:
Comorbidity of mental and somatic
disorders, psychosomatics
L-03
|
Lecture
284
Mental and physical multimorbidity